SILDENAFIL VERSUS INTRACAVERNOUS INJECTION THERAPY: EFFICACY AND PREFERENCE IN PATIENTS ON INTRACAVERNOUS INJECTION FOR MORE THAN 1 YEAR
- 1 October 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 164 (4), 1197-1200
- https://doi.org/10.1016/s0022-5347(05)67140-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- LOGISTIC REGRESSION AND SURVIVAL ANALYSIS OF 450 IMPOTENT PATIENTS TREATED WITH INJECTION THERAPY: LONG-TERM DROPOUT PARAMETERSJournal of Urology, 2000
- Reasons for discontinuing intracavernous injection therapy with prostaglandin E1 (alprostadil)Urology, 1999
- Use of sildenafil (Viagra) in patients with cardiovascular diseaseJournal of the American College of Cardiology, 1999
- Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South AfricaInternational Journal Of Impotence Research, 1998
- Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Long-term follow-up of patients receiving injection therapy for erectile dysfunctionUrology, 1997
- Predictors of Success and Risk Factors for Attrition in the Use of Intracavernous InjectionJournal of Urology, 1997
- Diffuse Veno-Occlusive Dysfunction: The Underlying Hemodynamic Abnormality Resulting in Failure to Respond to Intracavernous PharmacotherapyJournal of Urology, 1996
- Mechanisms of Venous Leakage: A Prospective Clinicopathological Correlation of Corporeal Function and StructureJournal of Urology, 1996